What Cognition Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 3 |
| Sells | 0 | 0 |
| Total trades | 0 | 26 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 1,724,175 |
| Disposed | 0 | 216,765 |
| Net activity | +0 | +1,507,410 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Fletcher Aaron G.l. | Director | Jun 17 | Grant / award · A | +25,000 | — | — | 81,229 |
| Monia Brett P | Director | Jun 17 | Grant / award · A | +25,000 | — | — | 73,500 |
| Richstone Ellen B | Director | Jun 17 | Grant / award · A | +25,000 | — | — | 83,500 |
| Wallace Peggy | Director | Jun 17 | Grant / award · A | +25,000 | — | — | 111,461 |
| Khattar Jack A. | Director | Jun 17 | Grant / award · A | +25,000 | — | — | 73,500 |
| Doyle John Brendan | Chief Financial Officer | May 01 | Withheld — tax / exercise cost · F | −8,567 | $1.28 | −$11K | 618,942 |
| Caggiano Anthony | Chief Medical Officer | Apr 16 | Open-market buy · P | +10,000 | $1.11 | +$11.1K | 874,906 |
| Ricciardi Lisa | CEO & President | Apr 16 | Open-market buy · P | +9,175 | $1.10 | +$10.1K | 1,715,851 |
| Doyle John Brendan | Chief Financial Officer | Apr 16 | Open-market buy · P | +10,000 | $1.13 | +$11.3K | 627,509 |
| Caggiano Anthony | Chief Medical Officer | Feb 15 | Withheld — tax / exercise cost · F | −4,680 | $1.12 | −$5.24K | 864,906 |
| Doyle John Brendan | Chief Financial Officer | Feb 15 | Withheld — tax / exercise cost · F | −1,560 | $1.12 | −$1.75K | 617,509 |
| Ricciardi Lisa | CEO & President | Feb 15 | Withheld — tax / exercise cost · F | −5,850 | $1.12 | −$6.55K | 1,706,676 |
| Ricciardi Lisa | CEO & President | Feb 04 | Withheld — tax / exercise cost · F | −51,704 | $1.03 | −$53.3K | 1,712,526 |
| Doyle John Brendan | Chief Financial Officer | Feb 04 | Withheld — tax / exercise cost · F | −26,921 | $1.03 | −$27.7K | 619,069 |
| Caggiano Anthony | Chief Medical Officer | Feb 04 | Withheld — tax / exercise cost · F | −26,919 | $1.03 | −$27.7K | 869,586 |
| Ricciardi Lisa | CEO & President | Feb 03 | Withheld — tax / exercise cost · F | −26,036 | $1.12 | −$29.2K | 1,764,230 |
| Ricciardi Lisa | CEO & President | Feb 03 | Grant / award · A | +800,000 | — | — | 1,790,266 |
| Doyle John Brendan | Chief Financial Officer | Feb 03 | Grant / award · A | +200,000 | — | — | 645,990 |
| Caggiano Anthony | Chief Medical Officer | Feb 03 | Withheld — tax / exercise cost · F | −11,488 | $1.12 | −$12.9K | 896,505 |
| Caggiano Anthony | Chief Medical Officer | Feb 03 | Grant / award · A | +400,000 | — | — | 907,993 |
Loading...
